FDA Media Alert Detail

Drug Shortage

FDA Drug Shortage: Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Injection

  • U.S. Food and Drug Administration
  • September 9, 2026
  • ID: shortage-imipenem-anhydrous-cilastatin-and-relebactam-anhydrous-injection-merck-sharp-dohme-llc-0006-3856-02

Drug Shortage Details

Generic NameImipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Injection
Manufacturer / CompanyMerck Sharp & Dohme LLC
Therapeutic CategoryAnti-Infective
Availability StatusShortage
Status (FDA list)To Be Discontinued
NDC Package Code0006-3856-02
Presentation & Dosage Form

RECARBRIO, Injection, 500 mg/100 mL; 500 mg/100 mL; 250 mg/100 mL (NDC 0006-3856-02)

Manufacturer Contact Info

800-672-6372


Content syndicated from the U.S. Food and Drug Administration (FDA) Drug Shortages Database.